NATIONAL MARROW DONOR PROGRAM

Lobbying for NATIONAL MARROW DONOR PROGRAM

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Expenses

$280,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Minnesota

Official filing document

Government bodies contacted 4

HOUSE OF REPRESENTATIVES
SENATE
Transportation Security Administration (TSA)
U.S. Customs & Border Protection

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 9

S 1227
ABC Act
HR 2491
ABC Act
HR 5160
Stem Cell Therapeutic and Research Reauthorization Act of 2025
S 752
Accelerating Kids’ Access to Care Act
HR 1509
Accelerating Kids’ Access to Care Act of 2025
S 925
Credit for Caring Act of 2025
HR 2036
Credit for Caring Act of 2025
HR 5178
Sickle Cell Disease Comprehensive Care Act
S 721
Sickle Cell Disease Comprehensive Care Act

Lobbying activity 3

Health Issues

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721.

Budget/Appropriations

Continued funding for the C.W. Bill Young Cell Transplantation Program. Increased funding to expand patient access to transplants. Increased medical research funding.

Transportation

Donated bone marrow/cell transportation for life-saving transplant.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.